
The newly launched product is in the strengths of 0.8 g and 2.4 g packets, and is a therapeutic equivalent generic version of Renvela (sevelamer carbonate) for oral suspension.
from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2VaNoI2
via
IFTTT
0 comments:
Post a Comment